Magnetic resonance imaging improves breast cancer diagnosis

Women who have been diagnosed with breast cancer in one breast have a higher risk of contracting the disease in their opposite breast as well. A thorough examination of the opposite breast using mammography and ultrasound is therefore common practice. However, many tumours still remain undetected when using mammography. Magnetic resonance imaging (MRI) promises better results, as is shown in an inter-national study involving the University of Bonn.

In almost 1,000 women with a recent diagnosis of breast cancer in one breast, MRI helped identify 30 cancers in the seemingly normal opposite breast . In women with a normal (negative) MRI of the opposite breast, there was a 99.6% confidence that in fact no breast cancer was present -- which means that if the MRI study is normal, preventive mastectomy of the opposite breast, which some women want, is definitely unnecessary . These findings have now been published in the prestigious journal New England Journal of Medicine.

About two dozen sites in North America participated in the study, as well as one sole site outside the USA, the University of Bonn. Bonn was selected as a team member due to its internationally leading position in breast cancer diagnostics. A total of 968 patients were examined, almost 200 of them at the University of Bonn alone. "Therefore, proportionally, most patients came from our Department, which means that the data from Bonn had a substantial impact on the results of the entire study," explains Professor Christiane Kuhl from the Department of Radiology of the University of Bonn. All the women had previously been diagnosed with tumours in one breast.

A mammography as well as a clinical examination of the opposite breast had remained normal and without evidence of breast cancer . The patients then underwent breast MRI .Using MRI, the doctors found tumours in the other breast in as many as 30 women, yielding a contralateral cancer yield of over 3% - which is a high rate given the fact that regular breast cancer screening yields a detection rate of around 1 per million.. "It is already well established that an MRI is essential before breast cancer surgery in order to delineate the extent of the disease and provide a road map for the surgeon. Now we know that it is also important for discovering further tumours in the opposite breast which was presumed to be healthy," Professor Kuhl says.

What is particularly reassuring for women with a recent diagnosis of breast cancer is that if the doctors did not discover a tumour on MRI, there was a 99.6% certainty that the breast indeed was free of cancer. "A prophylactic mastectomy of the opposite breast, which some patients want, is definitely unnecessary if an MRI shows no evidence of cancer," she emphasises.

Although the MRT is comparatively expensive, "it is definitely the most reliable method that is currently available for diagnosing breast cancer. Breast MRI should be considered the standard of care for screening women who carry an increased risk of breast cancer -- be it due to a strong family history, or, as our results show, due to a recent diagnosis of supposedly unilateral breast cancer," she says. "And women themselves should be aware of this."

Source: University of Bonn

Related stories:

MRI spots DCIS in mice
A new magnetic resonance imaging procedure can detect very early breast cancer in mice, including ductal carcinoma in situ (DCIS), a precursor to invasive cancer. Some of the tumors detected were less than 300 microns in diameter, the smallest cancers ever detected by MRI.
Study challenges routine use of MRI scans to evaluate breast cancer
A new study suggests women with newly-diagnosed breast cancer who receive an MRI after their diagnosis face delays in starting treatment and are more likely to receive a mastectomy. The study, presented today at the 2008 ASCO Breast Cancer Symposium, also shows that despite lack of evidence of their benefit, the routine use of MRI scans in women newly diagnosed increased significantly between 2004 and 2005, and again in 2006.
Potential remedy for the 'mental fog' in cancer patients
Cancer patients have complained for years about the mental fog known as chemobrain. Now in animal studies at West Virginia University (WVU), researchers have discovered that injections of N-acetyl cysteine (NAC), an antioxidant, can prevent the memory loss that breast cancer chemotherapy drugs sometimes induce. The WVU researchers' study has just been published in the September issue of the Springer journal Metabolic Brain Disease.
World first: Lasers used in keyhole surgery for brain cancer
In a ground-breaking advance, French neurosurgeons on Friday said they had successfully treated brain tumours through ultra-keyhole surgery, using a tiny fibre-optic laser to destroy cancerous cells.
Fireflies' glow helps researchers track cancer drug's effectiveness
The gene that allows fireflies to flash is helping researchers track the effectiveness of anti-cancer drugs over time.
Adding ultrasound to mammography may improve breast cancer detection in high-risk women
The addition of an ultrasound examination to mammography for women at high-risk of breast cancer resulted in a higher rate of cancer detection, but also increased the number of false-positive results, according to a study in the May 14 issue of JAMA.
Study shows gene variations may predict risk of breast cancer in women
According to a recent study, led by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial Hospital and assistant professor of medicine, Northwestern University Feinberg School of Medicine, variations of the adiponectin gene, which regulates a number of metabolic processes, may increase a woman’s risk of developing breast cancer. This discovery is an important step forward in cancer genetics research, as it could help experts develop a future genetic testing model to more accurately predict a woman’s risk of developing breast cancer.
Chemotherapy causes delayed severe neural damage
A commonly used chemotherapy drug causes healthy brain cells to die off long after treatment has ended and may be one of the underlying biological causes of the cognitive side effects – or “chemo brain” – that many cancer patients experience. That is the conclusion of a study published today in the Journal of Biology.

News discussion:

Medicine & Health news